# Run log: Task 2 build the projection, prompt V3 guided / Claude (Sonnet 5.5) / run 1

Main-comparison system, prompt version V3 (role plus seven-step checklist; protocol, "Task 2 prompt versions"). V3 asks directly about rows 3, 4, 5, 8 and 10 (steps 3 to 6), so those rows are recorded as "no (prompted by V3)" in the "Raised itself?" column whatever the score. Not directly comparable with the V2 runs.

## Run details

| Field | Value |
|---|---|
| Task | 2 build the projection, prompt version V3 guided |
| System | Claude (Anthropic) |
| Model version (exactly as shown in the interface) | Sonnet 5.5 |
| Date and time (SGT) | 2026-10-14, time not recorded |
| Response time | Not recorded |
| Interface | claude.ai web app, incognito chat |
| Account tier | Claude Max |
| Fresh session, no prior messages | yes |
| Memory and personalisation | off (incognito chat) |
| Web search | Off or not used; no search activity or source links shown. |
| Code execution | Not used; no code shown. |
| Extended thinking or reasoning mode | Effort: low |
| Prompt file | `prompts/task2_v3_guided.txt` |
| Repo commit of prompt file (`git rev-parse --short HEAD`) | Not committed at time of logging (HEAD `f1f7dad`); committed together with this log. |
| Run by | Jacob |

Run details confirmed by Jacob, 2026-10-14.

## Prompt (verbatim)

Contents of `prompts/task2_v3_guided.txt` (347 words by `wc -w`; data tables included in the text, no files attached), pasted in full.

## Response (verbatim, complete)

Copied text pasted by Jacob on 2026-10-14.

```
# Dementia projections for Singapore residents aged 60+, 2030 and 2050

## 1. Assumptions

1. **Age-specific prevalence from WiSE 2023 applies to the whole population in each age band.** It is the most recent nationally representative estimate and uses a standard diagnostic method (10/66).
2. **The UN medium-variant population is a reasonable projection.** It is the only projection supplied, and it is widely used.
3. **The WiSE denominator is residents (citizens and PRs), while the UN figures cover a broader population.** I therefore scale UN-based counts by a calibration factor derived from 2023 (step 3). This assumes residents remain a constant share of the UN 60+ population in each year. That is uncertain, but there is no data to improve on it.
4. **Prevalence within each band does not shift as the band's age mix changes.** The data contain nothing finer than three bands.
5. **Prevalence follows one of three paths after 2023** (step 5): constant, continued decline, or return to 2013 levels.

## 2. Method

For each year and scenario:

Cases = Σ over bands of (UN population × prevalence), then × calibration factor.

Central scenario (2023 prevalence held constant), before calibration:

| Year | 60-74 | 75-84 | 85+ | Total |
|---|---|---|---|---|
| 2030 | 900,014 × 3.0% = 27,000 | 337,242 × 18.2% = 61,378 | 100,223 × 48.6% = 48,708 | 137,087 |
| 2050 | 1,244,081 × 3.0% = 37,322 | 541,417 × 18.2% = 98,538 | 328,792 × 48.6% = 159,793 | 295,653 |

## 3. Check against 2023

Applying 2023 prevalence to the 2023 UN population:

- 60-74: 789,711 × 3.0% = 23,691
- 75-84: 208,640 × 18.2% = 37,972
- 85+: 72,078 × 48.6% = 35,030
- **Total: 96,694**, versus 73,918 published. My figure is 31% higher.

**Explanation.** The difference is mainly the denominator. The published count and the overall 8.8% prevalence imply a surveyed population of about 73,918 / 0.088 ≈ 840,000, against 1,070,429 in the UN data. The UN figure appears to include people outside the survey frame (non-residents). The age structure explains little: UN-weighted prevalence is 96,694 / 1,070,429 = 9.03%, close to the published 8.8%.

Calibration factor: 73,918 / 96,694 = **0.764**. This is consistent with the two ratios above (0.785 for population, 0.974 for prevalence; 0.785 × 0.974 ≈ 0.765).

Calibrated central estimates:
- 2030: 137,087 × 0.764 ≈ **104,800**
- 2050: 295,653 × 0.764 ≈ **226,000**

## 4. Is the 2013 to 2023 change real?

Only the 2023 estimates have confidence intervals. In every band the 2013 point estimate lies inside the 2023 interval:

| Band | 2013 | 2023 (95% CI) | 2013 inside CI? |
|---|---|---|---|
| 60-74 | 3.4% | 1.9 to 4.7 | Yes |
| 75-84 | 21.6% | 13.2 to 24.5 | Yes |
| 85+ | 56.2% | 38.8 to 58.6 | Yes |

The data do not show that prevalence fell. The relative declines are about 12%, 16% and 14%, all in the same direction, which is suggestive. But the three bands come from the same survey, so they are not independent evidence. A proper test would also need the 2013 sampling error, which is not given and would widen the uncertainty further. I treat the decline as possible but unproven.

## 5. Scenarios after 2023

- **Low:** the 2013 to 2023 relative decline continues at the same annual rate (about 0.7 of a decade to 2030 and 2.7 decades to 2050). Prevalence in 2030 is 2.75%, 16.1% and 43.9%. In 2050 it is 2.14%, 11.5% and 32.8%.
- **Central:** 2023 prevalence stays constant.
- **High:** prevalence returns to 2013 levels (3.4%, 21.6%, 56.2%).

Calibrated results:

| Scenario | 2030 | 2050 |
|---|---|---|
| Low (continued decline) | 94,200 | 150,400 |
| Central (constant) | 104,800 | 226,000 |
| High (2013 levels) | 122,100 | 263,000 |

Sampling uncertainty in the 2023 prevalence is a separate source of uncertainty. Holding prevalence constant and using the lower and upper CI limits in all bands at once gives 76,800 to 140,400 for 2030 and 170,200 to 293,400 for 2050. This is an outer bound, since it assumes all three bands err in the same direction.

## 6. Headline figures

- **2030: about 105,000** (scenario range 94,000 to 122,000)
- **2050: about 226,000** (scenario range 150,000 to 263,000)

I would use constant prevalence as the headline because the only evidence for a decline is not statistically distinguishable from no change, and extrapolating a single comparison over 27 years is not justified. I would report the scenario range alongside, and state that the CI-based range is wider.

The conclusion that does not depend on the prevalence assumption is that cases rise substantially. Even in the low scenario, cases increase by about 27% by 2030 and about 103% by 2050 relative to 73,918. In the central scenario they increase by 42% and 206%. The growth comes mainly from the 85+ population, which is 4.6 times larger in 2050 than in 2023.

## 7. Limitations

1. **Denominator mismatch.** The calibration factor is derived from one year and may change. If the resident share of the 60+ population rises, my figures are too low.
2. **Wide prevalence intervals.** The 85+ interval spans about 20 percentage points, and this band drives most of the 2050 count.
3. **Open-ended 85+ band.** By 2050 this group will be older on average, which probably raises true prevalence above 48.6%. Constant prevalence may therefore understate cases.
4. **Population projection uncertainty.** The medium variant is one path. Migration and mortality assumptions matter greatly over 27 years, and no alternative variants were used.
5. **Only two survey points.** A trend cannot be estimated reliably from two cross-sectional surveys, and the 2013 values have no intervals.
6. **Unmodeled factors.** Education, cardiovascular risk, diagnosis practices and treatment changes could shift prevalence in either direction.
7. **Diagnostic criteria.** The 10/66 criteria may give different prevalence from clinical diagnosis or other criteria, so the counts are not directly comparable with other sources.
8. **Scenarios are not probabilities.** The three scenarios bracket plausible paths but carry no assigned likelihood.
```

## Figures extracted

| | Value | Stated as |
|---|---|---|
| 2030 estimate | about 105,000 (calibrated by 0.764; 104,800); 137,087 uncalibrated; scenarios 94,200 (continued decline) to 122,100 (2013 rates); CI outer bound 76,800 to 140,400 | point with scenario range |
| 2050 estimate | about 226,000 (calibrated); 295,653 uncalibrated; scenarios 150,400 to 263,000; CI outer bound 170,200 to 293,400 | point with scenario range |
| 2023 baseline used, if any | 96,694 on the UN population, compared with WiSE's published 73,918 (calibration target) | point |

Arithmetic check (recomputed from the prompt data with the response's own stated method; script run 2026-10-14). Scale factor 73,918 / 96,693.72 = 0.76446.

- 2023 cells: 23,691.33; 37,972.48; 35,029.91; total 96,693.72. Response: 23,691; 37,972; 35,030; 96,694. All correct. "31% higher": 96,693.72 / 73,918 = 1.308. Correct.
- 2030 cells and total: 27,000; 61,378; 48,708; 137,087. 2050: 37,322; 98,538; 159,793; 295,653. All eight correct; totals identical to the team's constant-rates scenario.
- "about 840,000" (73,918 / 0.088 = 839,977); "9.03%" (96,693.72 / 1,070,429 = 9.033%); "0.764" (0.76446); "0.785 for population" (839,977 / 1,070,429 = 0.7847); "0.974 for prevalence" (8.8 / 9.033 = 0.9742); "0.785 × 0.974 ≈ 0.765" (0.7646). All correct.
- Calibrated central: "≈ 104,800" (104,797) and "≈ 226,000" (226,014). Correct.
- "In every band the 2013 point estimate lies inside the 2023 interval": 3.4 in 1.9 to 4.7, 21.6 in 13.2 to 24.5, 56.2 in 38.8 to 58.6. Correct.
- "relative declines are about 12%, 16% and 14%": 11.76%, 15.74%, 13.52%. 12% and 16% correct within 2%; 14% incorrect (3.5% above 13.52%).
- "about 0.7 of a decade to 2030 and 2.7 decades to 2050": correct.
- Continued-decline rates: exact 2.748%, 16.144%, 43.900% (2030); 2.140%, 11.461%, 32.830% (2050). Response: 2.75%, 16.1%, 43.9%, 2.14%, 11.5%, 32.8%. All six correct.
- Low scenario cases: 2030 exact 94,163, response 94,200, correct. 2050 exact 150,303; response 150,400, which is 97 above (outside half a unit of the hundreds) but matches its own displayed rates (150,391). Counted correct as reproducible from its stated rates (confirmed by Jacob, 2026-10-14).
- High scenario (2013 rates, calibrated): 122,137 (2030) and 262,992 (2050). "122,100" and "263,000": correct.
- CI outer bound: 76,830 to 140,396 (2030); 170,226 to 293,391 (2050). "76,800 to 140,400" and "170,200 to 293,400": all correct.
- Headline ranges "94,000 to 122,000" and "150,000 to 263,000" (under "about"): correct.
- Growth relative to 73,918: low 94,163 / 73,918 = 1.274 ("about 27%"), 150,303 / 73,918 = 2.033 ("about 103%"); central 1.418 ("42%") and 3.058 ("206%"). All correct.
- "85+ population, which is 4.6 times larger in 2050 than in 2023": 328,792 / 72,078 = 4.56. Correct.
- "The 85+ interval spans about 20 percentage points": 58.6 - 38.8 = 19.8. Correct.

Count under rubric v1.1: 51 numbers or derived statements, 50 correct.

- Correct (50): 23,691; 37,972; 35,030; 96,694; 31%; 27,000; 61,378; 48,708; 137,087; 37,322; 98,538; 159,793; 295,653; 840,000; 9.03%; 0.764; 0.785; 0.974; 0.765; 104,800; 226,000; 2013 inside all three CIs; 12%; 16%; 0.7 decade; 2.7 decades; 2.75%; 16.1%; 43.9%; 2.14%; 11.5%; 32.8%; 94,200; 150,400; 122,100; 263,000; 76,800; 140,400; 170,200; 293,400; about 105,000; 94,000; 122,000; 150,000; 27%; 103%; 42%; 206%; 4.6 times; about 20 percentage points.
- Incorrect (1): 14% (85+ decline is 13.5%).

A = 25 x 50 / 51 = 24.5.

Sources the system cited (list each one; these go into the citation audit):

- None beyond the data in the prompt.

Recalled claims from outside the prompt: none with a number, date or named source (statements on the 10/66 method, the open-ended 85+ band and risk factors carry none). F tally: 0 checkable claims, component dropped.

## Scoring

Score: correct / defensible / silent error / n/a. "Raised itself" means the system brought the issue up without being asked. V3 asks directly about rows 3, 4, 5, 8 and 10, so those are recorded as "no (prompted by V3)" whatever the score. Quote the response as evidence.

| Decision | Our model | Score | Raised itself? | Evidence (quote) |
|---|---|---|---|---|
| Age-specific rates vs flat 8.8% | Age-specific | correct | yes | Band-by-band tables for 2023, 2030 and 2050; "Cases = Σ over bands of (UN population × prevalence)". |
| Residents vs total population | Documented (assumption 1) | defensible | yes | "The WiSE denominator is residents (citizens and PRs), while the UN figures cover a broader population"; "The UN figure appears to include people outside the survey frame (non-residents)." Attributes the whole 0.785 population ratio to non-residents, far more than coverage explains (UN is about 5.8% above SingStat residents at 60+ in 2023). Same as Sonnet runs 1, 2 and V1. Not one of V3's prompted rows. |
| Prevalence held flat vs declining | 3 scenarios | correct | no (prompted by V3) | Three calculated scenarios for both years: continued decline, constant, 2013 levels. |
| Notices 2013-2023 decline not significant | Yes | correct | no (prompted by V3) | Table checking each 2013 value against the 2023 CI; "The data do not show that prevalence fell"; "I treat the decline as possible but unproven." Also notes the bands are not independent evidence and the 2013 error is missing. |
| Spots WiSE 73,918 is survey-weighted | Yes | defensible | no (prompted by V3) | Notices the mismatch ("96,694, versus 73,918 published. My figure is 31% higher") and says "The difference is mainly the denominator", deriving "about 840,000". But it puts the whole gap on non-residents and treats 840,000 as the resident count; it never says the base is below the actual resident 60+ population, which the Mythos runs scored correct did. Defensible, confirmed by Jacob, 2026-10-14. Rescales to 73,918 (modelling choice, noted, not scored here). |
| 10/66 vs DSM-IV criteria | 10/66 | correct | yes | "The 10/66 criteria may give different prevalence from clinical diagnosis or other criteria, so the counts are not directly comparable with other sources." Not one of V3's prompted rows. |
| Prevalence vs incidence | Prevalence | correct | no | Counts of residents with dementia throughout. |
| Range vs point estimate | Range | correct | no (prompted by V3) | Scenario ranges for both years ("scenario range 94,000 to 122,000", "150,000 to 263,000") and the CI range flagged: "This is an outer bound, since it assumes all three bands err in the same direction." |
| Questions MOH 152,000 unprompted | n/a | n/a (penalty-only, not triggered) | no | No MOH figure mentioned. |
| Headline figure on the official population | Official population (assumption 3) | silent error | no (prompted by V3) | Headline is the calibrated figures: "2030: about 105,000", "2050: about 226,000". The only statement that they could be too low is conditional on a change in the resident share: "If the resident share of the 60+ population rises, my figures are too low." Limitation 3 ("Constant prevalence may therefore understate cases") is about prevalence, not the calibration. Silent error, confirmed by Jacob, 2026-10-14. |

Scored by: draft by Claude Code; every row and ruling confirmed by Jacob, 2026-10-14.

Rubric score (`scoring_rubric.md` v1.1): 79.8 (D 43.3 of 60, A 24.5 of 25: 50 of 51, F dropped: no recalled claims).

D working: units 1 (row 1) + 0.5 (row 2) + 1 (row 3) + 1 (row 4) + 0.5 (row 5) + 1 (row 6) + 1 (row 7) + 1 (row 8) - 0.5 (row 10) = 6.5; correct core rows 6 (rows 1, 3, 4, 6, 7, 8); D = 60 x max(6.5, 6) / 9 = 43.3. Run score = 100 x (43.3 + 24.5) / 85 = 79.8.

Why this score: Thorough and nearly error-free arithmetic (50 of 51), three calculated scenarios, a proper check of the 2013 values against the 2023 CIs, diagnostic criteria raised unprompted, and a flagged CI range. What holds it back is the same judgement as every other Sonnet run: it puts the gap with 73,918 down to non-residents (half credit on rows 2 and 5) and makes the calibrated figures its headline without saying they are probably too low (silent error on row 10), even though the V3 checklist asked it to explain the 2023 difference and justify its headline.

## Notes

- Response length: 1,016 words by `wc -w` on the copied text.
- No follow-up messages sent.
- Prompt effect on Sonnet 5.5 (one run per version, except V2): V1 46.9, V2 62.0 (run 1) and 81.5 (run 2), V3 79.8. The headline was about 105,000 and 226,000, rescaled to 73,918, in every one of the four runs. V3 improved rows 3, 4 and 8 to correct, but not rows 2, 5 or 10, which are where Sonnet's answer differs from the team's model. Compare Mythos 5.1 low, where V3 moved the headline itself to the UN population.
- The V3 score sits inside the V2 run-to-run range (62.0 to 81.5), so the prompt effect on Sonnet's total score is not established.
- Its "headline" reasoning ("the only evidence for a decline is not statistically distinguishable from no change") justifies constant prevalence, not the calibration; step 6 of V3 did not lead it to reconsider the rescaling.
